Cargando…
Gastrointestinal malignancies harbor actionable MET exon 14 deletions
Recently, MET exon 14 deletion (METex14del) has been postulated to be one potential mechanism for MET protein overexpression. We screened for the presence of METex14del transcript by multiplexed fusion transcript analysis using nCounter assay followed by confirmation with quantitative reverse transc...
Autores principales: | Lee, Jeeyun, Ou, Sai-Hong Ignatius, Lee, Ji Min, Kim, Hee Cheol, Hong, Mineui, Kim, Sun Young, Jang, Jiryeon, Ahn, Soomin, Kang, So Young, Lee, Sujin, Kim, Seung Tae, Kim, Bogyou, Choi, Jaehyun, Kim, Kyung-Ah, Lee, Jiyun, Park, Charny, Park, Se Hoon, Park, Joon Oh, Lim, Ho Yeong, Kang, Won Ki, Park, Keunchil, Park, Young Suk, Kim, Kyoung-Mee |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4695055/ https://www.ncbi.nlm.nih.gov/pubmed/26375439 |
Ejemplares similares
-
MerTK is a novel therapeutic target in gastric cancer
por: Yi, Jun Ho, et al.
Publicado: (2015) -
MET gene alterations predict poor survival following chemotherapy in patients with advanced cancer
por: Ko, Jihoon, et al.
Publicado: (2022) -
An investigation of the role of gene copy number variations in sorafenib sensitivity in metastatic hepatocellular carcinoma patients
por: Lee, Ji Yun, et al.
Publicado: (2017) -
Patient-derived cell models as preclinical tools for genome-directed targeted therapy
por: Lee, Ji Yun, et al.
Publicado: (2015) -
Tissue recommendations for precision cancer therapy using next generation sequencing: a comprehensive single cancer center’s experiences
por: Cho, Minho, et al.
Publicado: (2017)